Rankings
▼
Calendar
LXRX FY 2021 Earnings — Lexicon Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
LXRX
Lexicon Pharmaceuticals, Inc.
$704M
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$298,000
-98.8% YoY
Gross Profit
-$55M
-18371.8% margin
Operating Income
-$87M
-29224.8% margin
Net Income
-$88M
-29449.0% margin
EPS (Diluted)
$-0.61
Cash Flow
Operating Cash Flow
-$87M
Free Cash Flow
-$88M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$137M
Total Liabilities
$23M
Stockholders' Equity
$114M
Cash & Equivalents
$64M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$298,000
$24M
-98.8%
Gross Profit
-$55M
$22M
-348.1%
Operating Income
-$87M
-$48M
-82.2%
Net Income
-$88M
-$59M
-49.8%
← Q4 2020
All Quarters
Q1 2021 →